177 related articles for article (PubMed ID: 37192644)
1. Development of an Immune Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Tumor Microenvironment.
Wang M; Song Q; Song Z; Xie Y
Horm Metab Res; 2023 Jun; 55(6):402-412. PubMed ID: 37192644
[TBL] [Abstract][Full Text] [Related]
2. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
3. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
5. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
6. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
Ren S; Wang W; Shen H; Zhang C; Hao H; Sun M; Wang Y; Zhang X; Lu B; Chen C; Wang Z
Front Oncol; 2020; 10():1496. PubMed ID: 32983989
[No Abstract] [Full Text] [Related]
8. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immune-related genes in clear cell renal cell carcinoma.
Wan B; Liu B; Huang Y; Yu G; Lv C
Aging (Albany NY); 2019 Dec; 11(23):11474-11489. PubMed ID: 31821170
[TBL] [Abstract][Full Text] [Related]
11. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Model for Clear-cell Renal Cell Carcinoma Based on Natural Killer Cell-related Genes.
Shi X; Yuan M; Yang Y; Wang N; Niu Y; Yang C; Dong A; Zhu H; Jia X
Clin Genitourin Cancer; 2023 Jun; 21(3):e126-e137. PubMed ID: 36513558
[TBL] [Abstract][Full Text] [Related]
13. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
Bao W; Han Q; Guan X; Wang Z; Gu M
Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
[TBL] [Abstract][Full Text] [Related]
14. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
[TBL] [Abstract][Full Text] [Related]
15. A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma.
Gu J; Zhang X; Peng Z; Peng Z; Liao Z
Sci Rep; 2023 Nov; 13(1):18922. PubMed ID: 37919459
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
Yang Y; Huang H; Liang H
J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
[TBL] [Abstract][Full Text] [Related]
17. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
Ju L; Shi Y; Liu G
PeerJ; 2022; 10():e14506. PubMed ID: 36570012
[TBL] [Abstract][Full Text] [Related]
19. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
